60 Degrees pharma focuses on Malaria treatment and clinical trials #health #malariatreatment

By Proactive Investors / August 30, 2024 / www.youtube.com / Article Link

60 Degrees Pharmaceuticals CEO Geoff Dow discussed the challenges facing the company in the current market environment.

Recent News

Gold stocks mixed after previous week's huge gains

September 23, 2024 / www.canadianminingreport.com

Large TSXV gold multiple driven up by high Artemis weighting

September 23, 2024 / www.canadianminingreport.com

Monetary-driven precious metals outperform major base metals

September 09, 2024 / www.canadianminingreport.com

Gold stocks hit by plunging equities markets

September 09, 2024 / www.canadianminingreport.com

Gold stocks down as metal and equities momentum fades

September 02, 2024 / www.canadianminingreport.com

See all >